202 related articles for article (PubMed ID: 26646564)
1. Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells.
Biray Avci C; Kurt CC; Tepedelen BE; Ozalp O; Goker B; Mutlu Z; Dodurga Y; Elmas L; Gunduz C
Tumour Biol; 2016 May; 37(5):6673-9. PubMed ID: 26646564
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
3. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
[TBL] [Abstract][Full Text] [Related]
4. Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.
Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
Clin Oral Investig; 2016 Nov; 20(8):2023-2035. PubMed ID: 26795621
[TBL] [Abstract][Full Text] [Related]
5. Effect of glucose deprivation on the expression of genes encoding glucocorticoid receptor and some related factors in ERN1-knockdown U87 glioma cells.
Riabovol OO; Tsymbal DO; Minchenko DO; Lebid-Biletska KM; Sliusar MY; Rudnytska OV; Minchenko OH
Endocr Regul; 2019 Oct; 53(4):237-249. PubMed ID: 31734653
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic regulation of EDN1, EDNRA, EDNRB, and ECE1 gene expressions in ERN1 knockdown U87 glioma cells.
Minchenko DO; Tsymbal DO; Riabovol OO; Viletska YM; Lahanovska YO; Sliusar MY; Bezrodnyi BH; Minchenko OH
Endocr Regul; 2019 Oct; 53(4):250-262. PubMed ID: 31734650
[TBL] [Abstract][Full Text] [Related]
7. Expression of insulin-like growth factor binding protein genes and its hypoxic regulation in U87 glioma cells depends on ERN1 mediated signaling pathway of endoplasmic reticulum stress.
Minchenko DO; Kharkova AP; Karbovskyi LL; Minchenko OH
Endocr Regul; 2015 Apr; 49(2):73-83. PubMed ID: 25960008
[TBL] [Abstract][Full Text] [Related]
8. Expression of IDE and PITRM1 genes in ERN1 knockdown U87 glioma cells: effect of hypoxia and glucose deprivation.
Minchenko DO; Khita OO; Tsymbal DO; Danilovskyi SV; Rudnytska OV; Halkin OV; Kryvdiuk IV; Smeshkova MV; Yakymchuk MM; Bezrodnyi BH; Minchenko OH
Endocr Regul; 2020 Jul; 54(3):183-195. PubMed ID: 32857715
[TBL] [Abstract][Full Text] [Related]
9. ERN1 knockdown modifies the hypoxic regulation of TP53, MDM2, USP7 and PERP gene expressions in U87 glioma cells.
Danilovskyi SV; Minchenko DO; Moliavko OS; Kovalevska OV; Karbovskyi LL; Minchenko OH
Ukr Biochem J; 2014; 86(4):90-102. PubMed ID: 25509187
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptor, IRS1, IRS2, INSIG1, INSIG2, RRAD, and BAIAP2 gene expressions in glioma U87 cells with ERN1 loss of function: effect of hypoxia and glutamine or glucose deprivation.
Minchenko DO; Kharkova AP; Hubenia OV; Minchenko OH
Endocr Regul; 2013 Jan; 47(1):15-26. PubMed ID: 23363253
[TBL] [Abstract][Full Text] [Related]
11. The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines.
Fragni M; Bonini SA; Bettinsoli P; Bodei S; Generali D; Bottini A; Spano PF; Memo M; Sigala S
Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):529-38. PubMed ID: 26905520
[TBL] [Abstract][Full Text] [Related]
12. ERN1 knockdown modifies the effect of glucose deprivation on homeobox gene expressions in U87 glioma cells.
Tsymbal DO; Minchenko DO; Khita OO; Rudnytska OV; Viletska YM; Lahanovska YO; He Q; Liu K; Minchenko OH
Endocr Regul; 2020 Jul; 54(3):196-206. PubMed ID: 32857719
[TBL] [Abstract][Full Text] [Related]
13. Glucose deprivation affects the expression of genes encoding cAMP-activated protein kinase and related proteins in U87 glioma cells in ERN1 dependent manner.
Ratushna OO
Endocr Regul; 2020 Nov; 54(4):244-254. PubMed ID: 33885249
[No Abstract] [Full Text] [Related]
14. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
[TBL] [Abstract][Full Text] [Related]
15. INHIBITION OF ERN1 SIGNALING ENZYME AFFECTS HYPOXIC REGULATION OF THE EXPRESSION OF E2F8, EPAS1, HOXC6, ATF3, TBX3 AND FOXF1 GENES IN U87 GLIOMA CELLS.
Minchenko OH; Tsymbal DO; Minchenko DO; Kovalevska OV; Karbovskyi LL; Bikfalvi A
Ukr Biochem J; 2015; 87(2):76-87. PubMed ID: 26255341
[TBL] [Abstract][Full Text] [Related]
16. Expression of phosphoribosyl pyrophosphate synthetase genes in U87 glioma cells with ERN1 knockdown: effect of hypoxia and endoplasmic reticulum stress.
Minchenko OH; Garmash IA; Kovalevska OV; Tsymbal DO; Minchenko DO
Ukr Biochem J; 2014; 86(6):74-83. PubMed ID: 25816608
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells.
Bringmann A; Schmidt SM; Weck MM; Brauer KM; von Schwarzenberg K; Werth D; Grünebach F; Brossart P
Leukemia; 2007 Apr; 21(4):732-8. PubMed ID: 17301819
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid effects interleukin-6 expression in hormone-independent prostate cancer cell lines.
Asbagh LA; Uzunoglu S; Cal C
Int Braz J Urol; 2008; 34(3):355-63; discussion 364. PubMed ID: 18601766
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid induces micronuclei formation, mitochondrial-mediated apoptosis and cytostasis in kidney cells.
Singireesu SSNR; Mondal SK; Yerramsetty S; Misra S
Life Sci; 2018 Jun; 203():305-314. PubMed ID: 29729261
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
Huang X; Huang S; Guo F; Xu F; Cheng P; Ye Y; Dong Y; Xiang W; Chen A
Mol Med Rep; 2016 Jan; 13(1):613-22. PubMed ID: 26648136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
